---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-046572"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:58:33.088224+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma raises CSO and CFO salaries and bonus targets effective Jan 1, 2024

## Summary
- CSO Kishor Bhatia base salary increased to $316,000; target bonus set at 40% of base.
- CFO David Margrave base salary increased to $413,800; target bonus set at 40% of base.
- Changes effective January 1, 2024, based on independent compensation advisory firm analysis.
- Amendments to employment agreements approved by Compensation Committee and Board.

## SEC filing metadata
- accession: 0001493152-23-046572
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/0001493152-23-046572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-046572
- JSON: https://secwatch.observer/filing/0001493152-23-046572.json
- Plain text: https://secwatch.observer/filing/0001493152-23-046572.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.